Introduction
============

Pulmonary parenchymal disease includes diseases of the alveoli, microvasculature, and interstitial tissue.[@b1-vmrr-7-019] Interstitial lung diseases (ILDs) are a group of poorly defined diseases with pathology largely limited to the interstitial space between the basement membrane and the capillaries (alveolitis) but can extend to the peribronchiolar region.[@b2-vmrr-7-019] The proposed pathogenesis is irritation of the alveolar epithelial lining, specifically type I alveolar epithelial cells (inhaled or hematogenous), triggering a host inflammatory response (profibrocyte and pro-inflammatory cytokine release) with subsequent deposition of extracellular matrix and fibrosis.[@b3-vmrr-7-019] Fibrin formation is critical in the pathogenesis of these diseases, and abnormal fibrinolysis could play a role as does an imbalance of matrix metalloproteinases and tissue metalloproteinase inhibitors.[@b4-vmrr-7-019]

Pulmonary hypertension (PH) is characterized by historical findings that include lethargy and reduced exercise tolerance, cough, dyspnea, syncope, and clinical signs that include a diastolic pulmonary valve murmur, systolic murmurs, adventitious lung sounds, cyanosis, and jugular venous distension.[@b5-vmrr-7-019] The clinical definition of PH is a persistent mean and systolic pulmonary pressure exceeding 20 and 30 mmHg, respectively, as measured by cardiac catheterization or indirectly using Doppler-derived measure of a tricuspid regurgitation velocity of ≥2.8 m/s or a pulmonary insufficiency of velocity of ≥2.2 m/s in the absence of tricuspid valve dysplasia or pulmonic stenosis, respectively.[@b5-vmrr-7-019],[@b6-vmrr-7-019] PH has been described as a complication of a number of idiopathic or secondary cardiopulmonary diseases.[@b7-vmrr-7-019] A classification system categorizes the etiologies into idiopathic or secondary, which are further grouped according to anatomical location, precapillary, capillary, or postcapillary.[@b5-vmrr-7-019],[@b8-vmrr-7-019] Precapil lary etiologies include congenital systemic to pulmonary shunts (atrial septal defects, ventricular septal defects, and patent ductus arteriosus), heartworm disease, pulmonary thromboembolism (caused by immune-mediated hemolytic anemia, neoplasia, hyperadrenocorticism, early phase of disseminated intravascular coagulation, or trauma), or direct compression of pulmonary arteries by granulomas or neoplasia. Capillary causes include chronic obstructive pulmonary disease, interstitial pulmonary fibrosis, neoplasia, high altitude disease, and reactive pulmonary vascular resistance. Postcapillary cause is left-sided heart disease (mitral valve disease, myocardial disease). The pathophysiology of PH is multifactorial, and proposed mechanisms include alveolar hypoxia with reflex vasoconstriction, release of antithrombin, activated clotting cascade, platelet-mediated vascular remodeling, vasoconstriction (thromboxane, histamine, serotonin, and endothelin 1), retarded vasodilation (decreased nitrous oxide, prostacycline, endothelin relaxing factor), and primary pulmonary pathological processes and inflammation.[@b7-vmrr-7-019] In heartworm disease and systemic pulmonary shunts, the mechanism is intimal proliferation and fibrosis due to release of parasite toxins in the former and shear stress from increased blood velocities in the latter. In pulmonary or airway disease, hypoxia induces reflex vasoconstriction, and hypoxemia-induced polycythemia can contribute to shear stress. In left-sided heart disease, the cause is simple mechanics of increased pulmonary capillary wedge pressure.

This study investigates the historical, clinical, radiographic, computed tomography (CT), and clinical pathological findings in Pekingese dogs suffering from PH and chronic, clinically progressive, idiopathic pulmonary parenchymal disease thought to be ILD. A lung pathological involvement severity scoring system was utilized to indirectly assess lung pathology objectively on thoracic radiographs and CT.

Materials and methods
=====================

Animals
-------

For this retrospective study, medical records of all dogs presented to Peace Avenue Veterinary Clinic, Hong Kong, between October 1, 2009, and September 30, 2012, were searched for cases of Hong Kong Pekingese dogs diagnosed with respiratory disease consistent with lower airway disease that had accompanying PH confirmed on echocardiography.

Ethics approval and owner consent was not required as this was a retrospective study, no animal was subjected to an intervention, and lastly, owner information was not recorded.

Inclusion criteria
------------------

The search criteria used included "Pekingese" and "syncope" or "collapse" or "cyanosis" or "pulmonary hypertension" or "interstitial lung pattern". Medical records were reviewed in detail, and only those cases with complete medical records, including history, complete blood count, serum biochemistry results, and thoracic radiographs, were included. Data were entered using Excel spreadsheets. If CT, bronchoscopy, and bronchoalveolar lavage (BAL) were performed, the results were included. Blood gas analyses were infrequently performed and were not included in the study. The signalment was determined by the written medical record. Historical findings of exercise intolerance, cyanosis, dyspnea, syncope, and coughing were recorded, and if possible, the duration of the preceding clinical signs prior to presentation was calculated. The reason for seeking veterinary opinion was recorded.

In order to include as many possible cases with this syndrome, it was necessary to include both objective (Doppler) and subjective (B-mode and M-mode) echocardiographic diagnoses of PH. Echocardiography included two-dimensional (B-mode) M-mode, and in a few cases Doppler interrogation of the valves using standard views in unsedated dogs using either a MYLAB 30 vet (Esoate, Italy) or a GE Vivid E9 (General Electric Co., GE Vingmend Ultrasound A/S, Horten, Norway). Many examinations were abbreviated due to severe respiratory compromise. Studies were performed using a 6--9 MHz probe for the MYLAB 30 vet and the 6 S-D (2.7--8 MHz) and 12 S-D (4--12 MHz) probe for the GE Vivid E9. All Digital Imaging and Communications in Medicine (DICOM) still and cine images were reviewed by the primary investigator. For those dogs in which objective inclusion criteria (Doppler) were used (n=9), right ventricular (RV) to right atrial pressure gradient was calculated by application of the modified Bernoulli equation (Δ*P* = 4 × velocity[@b2-vmrr-7-019]) to the maximal tricuspid regurgitation velocity. A peak tricuspid regurgitation of ≥2.8 m/s was considered indicative of PH. In the absence of Doppler interrogation (n=26), a combination of subjective inclusion criteria was used to define moderate-to-severe PH as follows: RV hypertrophy and dilation, decreased left ventricular size and flattening, or paradoxical septal motion of the interventricular septum.[@b5-vmrr-7-019],[@b9-vmrr-7-019]

Exclusion criteria
------------------

Exclusion criteria included Pekingese with concurrent chronic mitral valvular disease classified according to the American College of Veterinary Internal Medicine (ACVIM) consensus statement B2 or higher, *Dirofilaria immitis* infection, pulmonic valve stenosis, and uncorrected patent ductus arteriosus.[@b10-vmrr-7-019] If the dog was not on regular heartworm prophylaxis, then only if a *D. immitis* ELISA antigen test (SNAP®, Heartworm RT test, IDEXX) was found to be negative at the time of diagnosis, could the dog be included in the study. Pulmonic valve stenosis was ruled out echocardiographically based on lack of deformity or narrowing of the pulmonic valve region, absence of poststenotic dilation of the pulmonary artery, normal excursion of the valve leaflets, and no high-velocity turbulent systolic pulmonary artery flow if Doppler was performed.

Clinical findings
-----------------

Clinical examination results for the first consultation, including body weight (kg), heart rate (beats per minute\[bpm\]), respiratory rate (breaths per minute\[bpm\]), rectal temperature (°C), cyanosis of the mucous membranes, respiratory description (dyspnea), and the presence of, and if recorded the type of, crackles audible on auscultation of the lungs were recorded. Venous blood was collected for complete blood counts (Procyte Dx® Hematology Analyzer, IDEXX VetLab®, Westbrook, ME, USA) and serum biochemistry analyses (Catalyst®, Chemistry Analyzer, IDEXX VetLab) as part of the initial investigation.

Diagnostic imaging
------------------

Standard thoracic radiographs (right lateral and dorsoventral thoracic views) were acquired using direct digital radiography technique (Definium™ 8000 X-ray system, General Electric Company, Waukesha, WI, USA), and electronic calipers were used for measurements that were made from the outer surface of vessels or bronchi. The primary investigator evaluated the thoracic radiographs, including cardiac silhouette chamber enlargement, lung pattern and distribution, pulmonary artery-to-adjacent vein ratios at the level of the fourth intercostal space on the lateral views for the left cranial lobar pulmonary artery (CrPA) and vein (CrPV), and the ninth intercostal space on dorsoventral view for the caudal lobar pulmonary artery (CdPA) and vein (CdPV). Vertebral heart score and the diameter of the caudal vena cava were measured on the lateral views as well as an assessment of whether the cardiac apex was elevated, an indication of RV wall concentric hypertrophy, and if present then classified subjectively as either mild, moderate, or severe based on the degree of "lifting" of the apex from the sternum. Arteries and veins were measured perpendicular to the vessel at the thickest diameter. A lung pathological involvement severity scoring system was developed. Each lung lobe (right cranial, right middle, right caudal, and accessory and left cranial pars cranialis and pars caudalis and left caudal) was allocated a score (0--3) depending on severity and extent of lung pattern, with the score of 1 indicating mild (interstitial pattern) and the score of 3 indicating severe lung involvement (alveolar pattern). A cumulative lung severity score (0--21) was the sum of the seven individual lung lobe scores.

Survey and postcontrast CT images were acquired by a manual injection of iohexol (Omnipaque, GE Healthcare Inc., Waukesha, WI, USA) at a dose of 600 mg I/kg. CT was performed with the dog in sternal recumbency under general anesthesia, using a helical dual slice scanner (General Electric Co., GE Health Care, CT Goldseal Hispeed NXI, Waukesha, WI, USA) with a sliding table and fixed gantry. The standard protocol was to ensure that dogs remained in sternal recumbency prior to CT to avoid atelectasis. Dogs were imaged from caudal to cranial with a slice thickness of 2 mm. A manual breath-hold technique was performed by the primary investigator, observing health and safety standards (lead-lined gown, gloves, thyroid shield, and a protective body shield) inflating the lung to an inspiratory pressure of between 10 and 15 cm water for a scan time of \<60 seconds. Images were sequential 2 mm collimated transverse images using lung algorithms. Analysis of the DICOM images was performed on a dedicated viewing station by a board-certified radiologist and the primary investigator using commercially available software (K-PACS, IMAGE Information Systems Ltd., London, UK). A semiobjective CT nonaeration lung index was developed by evaluating the Hounsfield unit (HU) of each lung lobe on a representative transverse slice of the worst affected part of the lobe. Taking the HU of normal lung as −713, a percentage decreased aeration was determined for each lobe, and then the contribution of each lobe to the total lung volume[@b11-vmrr-7-019] was taken into consideration to determine a total lung aeration loss for each dog stated as a pathological lung index score with 0= normal and 100= all lungs consolidated. These data were also compared to the more subjective radiologically determined percentage of lung involvement. The main pulmonary artery diameter (dMPA), measured on transverse view at just distal to the bifurcation, and ascending aorta diameters (dAas) were measured using electronic calipers on the same transverse slice, and a ratio was determined. Internal bronchial lumen-to-adjacent pulmonary arterial (BA) ratios were measured as described previously.[@b12-vmrr-7-019] The right and left internal ventricular diameters at their maximum width on a transverse image were measured, and the right-to-left ratio was determined.

Bronchoscopy and BAL
--------------------

Bronchoscopy was performed after imaging and under the same anesthetic used for the CT. A 2.8 mm flexible bronchoscope (BF-XP160F; Olympus Corporation, Tokyo, Japan) was used followed by a blind BAL of the right caudal lung lobe using an 8-FG red rubber feeding tube and 20 mL of sterile saline. The lavage fluid was submitted for cytology, aerobic and fungal culture, and sensitivity. Quantitative cultures were not available.

Outcome
-------

The time from first diagnosis until recorded time of death ascribable to PH complications was recorded as survival time. If the dog was still alive at the end of the investigation period, it was marked as alive. Treatments prescribed for the management of ILD or PH were noted, with dosages and dosing intervals.

Statistics
----------

Bayesian descriptive statistics were used. Excel software was used to calculate the means or the medians and interquartile range (IQR) of the continuous data depending on the distribution of the data.

Results
=======

Animals and clinical findings
-----------------------------

A total of 141 Pekingese with respiratory disease and PH were identified on the medical records based on the search criteria, from which 106 dogs were excluded based on the criteria described. The signalment, historical and clinical signs, and outcome for the individual dogs are summarized in [Table 1](#t1-vmrr-7-019){ref-type="table"}.

The mean age of the remaining 35 Pekingese was 14.5 years (range: 7--19 years), with 21 males and 14 females. The average body mass was 5.65 kg (range: 3.1--9 kg). Only 16 of the 35 dogs had a history of a mild chronic cough, but 24 dogs had a history of at least one or more episodes of syncope, and in 30 dogs, there was description of exercise intolerance by the owner. The onset of clinical signs preceded presentation by a median of 60 days (IQR 4.5--255 days). The clinical signs at presentation included dyspnea (71%) and cyanosis (40%). Twenty-nine dogs (83%) had audible crackles on auscultation located caudodorsally, both uni- and bilaterally. These were described as soft and classified as "velcro" crackles by the primary author who was responsible for managing the majority of the dogs included in the study. Vital parameters recorded at presentation included median heart rate (125 bpm; IQR 120--155 bpm), respiratory rate (42 bpm; IQR 25--66 bpm), and rectal temperature (38.4°C; IQR 37.7°C--38.6°C). Mild, nonregenerative normocytic, normochromic anemia was detected in two dogs on hematology. Moderately increased, blood urea nitrogen (37 mmol/L, reference interval 2.5--9.6 mmol/L) and alanine aminotransferase (226 U/L, reference interval 10--100 U/L) were found in one of the dogs with anemia. The latter dog had ascites that was a modified transudate (fluid analysis, total protein 44 g/L, low cell count) believed to be from right heart failure.

Diagnostic imaging
------------------

The predominant radiographic lung pattern was diffuse interstitial (n=20) to bronchointerstitial (n=7) or patchy alveolar patterns (n=1) ([Figures 1](#f1-vmrr-7-019){ref-type="fig"} and [2](#f2-vmrr-7-019){ref-type="fig"}). Seven dogs (20%) had normal appearing lungs. The median cumulative radiographic lung severity score was 3 (IQR 1.75--4). The cardiac silhouette had evidence of right heart enlargement in 23 dogs (66%) with a median vertebral heart score of 9.5 (IQR 9--10.5). The cardiac apex was elevated on the right lateral thoracic radiograph to a minor extent in ten dogs, moderately in four dogs, and severely in six dogs ([Figure 2](#f2-vmrr-7-019){ref-type="fig"}). The median CrPA and CdPA to vein ratio (PA/PV) was 1.1 (IQR 0.97--1.4; n=21) and 1.0 (IQR 1.0--1.3; n=18) measured on the lateral and dorsoventral thoracic radiographs, respectively, in those dogs that the measurement could be made.

CT was performed in five dogs. The following pathology was present: parenchymal bands (n=3), moderate subpleural interstitial thickenings (n=2), moderate peribronchiolar interstitial thickening (n=4), nodules (n=1), consolidated lung obscuring vessels (n=2), traction bronchiectasis (n=3), calcification (n=2), and honeycombing (n=3) ([Figures 3](#f3-vmrr-7-019){ref-type="fig"} and [4](#f4-vmrr-7-019){ref-type="fig"}). The mean dMPA was 12.1 mm (range: 9.5--17.2 mm; n=5) and dAa was 10.7 mm (range: 8.4--12.5 mm; n=5), and the ratio was 1.1 (range: 0.76--1.63) ([Figure 5](#f5-vmrr-7-019){ref-type="fig"}). The mean BA (n=6) was 0.72 (range: 0.5--0.93). In only three dogs could the ventricular internal diameters be measured. The internal diameter of the right ventricle was on average 106% the size of the left ventricle (range: 97%--118%). The mean of the total CT nonaeration lung index was 25.3 (range: 8.5--43.3). The findings in the five dogs that underwent both thoracic radiography and CT are described in [Table 2](#t2-vmrr-7-019){ref-type="table"}.

Bronchoscopy and BAL
--------------------

Bronchoscopy and BAL were performed in five dogs, and none of these dogs had obvious macroscopic changes consistent with chronic bronchial pathology except for thick inspissated mucus adhering to the bronchial walls of all dogs. The BAL cytology was consistent with inflammation in only two dogs with the predominant cellular component being neutrophils (range: 50%--80%), with no organisms visible. Two of the five dogs, the same two dogs that had inflammatory cells recovered in the BAL and one dog with only macrophages, which was considered normal, had positive cultures of *Klebsiella pneumoniae*, *Pseudomonas* spp., and *Candida albicans*, respectively. No quantitative cultures were performed.

Treatment
---------

All dogs were medicated chronically with sildenafil (Viagra, Pfizer) with doses ranging from 1.13 to 2.72 mg/kg, orally three times daily for the treatment of PH. In addition, other drugs that were used to manage these dogs included antibiotics (amoxicillin--clavulanate, enrofloxacin), bronchodilators (theophylline), and oral (prednisolone) and inhaled corticosteroids (beclomethasone).

Outcome
-------

By the end of the study period, 25 dogs had died as a consequence of the respiratory disease and were suffering from a respiratory crisis at the time of death. An additional two dogs were euthanized due to the grave prognosis (mortality rate 77%). The recorded clinical signs in the medical record at the time of the death were either syncope or dyspnea. At the time of sampling completion, the median survival during the 3-year period was 60 days (IQR 9--210 days).

Discussion
==========

This clinical case series describes 35 Pekingese that suffered from a chronic pulmonary parenchymal disease and associated PH. There was an expected high mortality rate (77%) and a short median survival from the time of diagnosis (60 days). This poor prognosis is not very different to previous reports of mortality associated with PH varying from 3 to 90 days, and these reports were of heterogeneous populations with severity thought to be worse in those cases having pulmonary etiologies (capillary).[@b5-vmrr-7-019],[@b13-vmrr-7-019] The incidence of this disease was assumed to be much higher in the population sampled as most of the 106 dogs could not be included in the study due to incomplete imaging records. Pekingese are a fairly popular breed in Hong Kong, but this alone is unlikely to account for the high incidence rate of this syndrome. This new described syndrome of an unknown etiology should be an important differential for dyspnea in this breed.

The most common cause of ILD in dogs is eosinophilic bronchopneumopathy (EBP) and is usually secondary to parasitic infections.[@b14-vmrr-7-019] Idiopathic pulmonary fibrosis (IPF) is the most frequently documented idiopathic ILD in dogs, although a rare disease, and a cause of PH, which has been not only well documented in the West Highland white terrier (WHWT) but also described in other terrier breeds.[@b15-vmrr-7-019]--[@b17-vmrr-7-019] Other types of idiopathic ILD have been described in case reports or case series and include histiocytosis X, cryptogenic organizing pneumonia (COP), sarcoidosis, hypersensitivity pneumonitis, steroid-responsive pneumonitis, pulmonary alveolar proteinosis, Sjögren's syndrome, silicosis, and asbestosis.[@b1-vmrr-7-019],[@b3-vmrr-7-019],[@b18-vmrr-7-019] Pulmonary parenchymal diseases, both alveolar and ILD, reported to cause PH include IPF, chronic pulmonary disease, mineralization, neoplasia, and, parasitic causes (*D. immitis* and *Angiostrongylus vasorum*).[@b5-vmrr-7-019],[@b8-vmrr-7-019],[@b19-vmrr-7-019],[@b20-vmrr-7-019] Rare idiopathic ILDs in dogs are diagnosed by a combination of signalment, the chronic nature of the disease, clinical findings, imaging studies, including thoracic radiographs and CT, and exclusion of other causes of cardiac and respiratory pathology and finally confirmed with histopathology of a lung biopsy. The accompanying PH in these Pekingese is indicative of the severity and chronicity of the pulmonary parenchymal disease. There are many parallels between this syndrome in geriatric Pekingese and IPF in WHWT, the best characterized of the ILD, but none of the pathology described is specific for IPF and further IPF is not steroid responsive.[@b21-vmrr-7-019],[@b22-vmrr-7-019] Other rare ILDs should be considered as differentials that share many of the same clinical and radiological findings. Cytology of BAL and/or radiographic findings can differentiate some of these ILDs. EBP could have alveolar, interstitial, or bronchial lung pattern, but BAL is distinctive in that there is an overwhelming eosinophilic inflammation.[@b23-vmrr-7-019] CT findings in EBP include pulmonary parenchymal abnormalities, specifically ground-glass pattern, consolidation, and nodules, bronchial wall thickening, plugging of the bronchial lumen by mucous, bronchiectasis, and lymphadenopathy.[@b24-vmrr-7-019] The most commonly reported thoracic radiographic findings in WHWT with IPF were a bronchointerstitial pattern and patchy alveolar opacities with indistinct margins in one or two lung lobes, a wide distribution throughout the lung field of an interstitial lung pattern, and bronchial markings with right-sided heart enlargement.[@b15-vmrr-7-019],[@b19-vmrr-7-019],[@b23-vmrr-7-019] Histiocytosis X is characterized by nodular infiltrates on radiographs and atypical histiocytes on BAL; sarcoidosis is typified by lymphadenopathy, bullae, and cysts with epitheliod cells, multinucleated giant cells, with lymphocytes and plasma cells on BAL.[@b3-vmrr-7-019] The radiographic pattern in two dogs with steroid-responsive pneumonitis had patchy alveolar opacities and a diffuse bronchointerstitial lung pattern.[@b18-vmrr-7-019] The dogs in our study predominantly had a diffuse interstitial to bronchointerstitial mixed pattern and rarely patchy alveolar infiltrates. More recently, a number of biomarkers measured on BAL fluid have shown promise in identifying ILD, specifically IPF in WHWT including chemokines such as CCL2.[@b25-vmrr-7-019] ILD appears to be the most likely cause of the pulmonary parenchymal disease in this group of Pekingese based on the chronic history, the associated PH, the soft crackles audible on auscultation, and nonspecific imaging findings. A notable feature in our case series was the report of audible pulmonary crackle on auscultation, similar to the velcro crackle described in many ILDs described in humans. An alternative explanation is that the pulmonary lesions visible radiographically correspond to the noncardiogenic pulmonary alveolar infiltrates that are associated with PH that develop in a diffuse patchy distribution, suspected to be interstitial pulmonary fibrosis recently described in ten dogs.[@b26-vmrr-7-019] These have been described to resolve with the treatment with sildanefil. The dogs in that case study presented with acute onset of dyspnea, syncope, in conjunction with an audible heart murmur, as is the case in the dogs described in our study.

The mean age at presentation of this group of Pekingese (14.5 years; range: 7--19 years) was slightly older than WHWT with IPF.[@b4-vmrr-7-019]--[@b6-vmrr-7-019],[@b13-vmrr-7-019] Pekingese had a history of exercise intolerance or syncope up to 255 days prior to presentation indicative of an underlying chronic ILD. Clinical findings included tachypnea, dyspnea, syncope, and cyanosis. Coughing was not a very significant feature in the history or clinical findings. Clinical findings in the ILD reports included at least one of the following: coughing, exercise intolerance, breathlessness, tachypnea, syncope, and collapse.[@b21-vmrr-7-019],[@b27-vmrr-7-019]

A recent publication reported that the mean CrPV/CrPA and CdPV/CdPA in dogs without cardiac disease (controls) were 0.99±0.6 and 1.04±0.19, respectively, as the focus of the study was venous congestion.[@b28-vmrr-7-019] Our study measured arterial-to-venous ratios as pulmonary artery dilation is the main vascular radiological pattern of PH. An additional discrepancy between this paper and ours was that our CdPA/CdPV measurements were made at the level of the ninth as opposed to the eleventh intercostal space. When the control dogs from the previous study had their mean CrPV and CdPV to respective artery ratios inverted, the mean ratios (1.01 and 0.96, respectively) were very similar to our measure of CrPA and CdPA to vein ratios (1.1, IQR 0.97--1.4; n=21 and 1.0, IQR 1.0--1.3; n=18). The evaluation of the cranial and caudal lobar pulmonary arteries and the ratios of these arteries relative to the adjacent veins offered very little diagnostic value in detecting severe PH in our dogs.

CT detected several lung lesions, with the majority located in the dorsocaudal lung lobes. The unique CT pattern of IPF is described as ground-glass, parenchymal bands, subpleural lines, moderate subpleural interstitial thickenings, moderate peribronchiolar interstitial thickening, consolidation, traction bronchiectasis, and honeycombing.[@b17-vmrr-7-019],[@b19-vmrr-7-019] The CT findings in the few reported cases of canine COP and steroid-responsive pneumonitis were bilateral asymmetric areas of air space consolidation and multifocal subpleural and peribronchial poorly defined nodular opacities, ground-glass opacities, and parenchymal bands.[@b18-vmrr-7-019],[@b27-vmrr-7-019] The five dogs that underwent CT had all the described patterns of ILD. An association in IPF has been reported between the number of lobes affected with ground-glass appearance and interstitial lung pathology on CT becoming more diffuse in pattern as the clinical disease worsened.[@b17-vmrr-7-019] Subpleural interstitial thickening, parenchymal bands, and peribronchovascular interstitial thickening are associated with moderate and severe stage of IPF, and traction bronchiectasis is found in the severest form of the disease.[@b17-vmrr-7-019]

In human CT studies, it has been established that the diameters and cross-sectional area of the pulmonary arteries measured from CT scans can be used as an indicator of PH and as an index for calculating pulmonary artery pressure noninvasively, but in pulmonary fibrosis and other ILDs, the pulmonary artery can dilate without PH and does not become a reliable predictor.[@b29-vmrr-7-019]--[@b31-vmrr-7-019] Thus, a potentially more reliable index for PH in patients with pulmonary fibrosis and other causes of ILD is the ratio of the dMPA to the dAa examined on the same transverse slice of the level of the pulmonary artery bifurcation and the widest short-axis dAa, and the mean ratio was found to be 1.1.[@b30-vmrr-7-019] A later study found that the diameter of the PA and the cross-sectional area of the PA as a ratio to the ascending aorta correlated equally well to the invasive PA measurement.[@b32-vmrr-7-019] Our dogs had a mean ratio of 1.1 (range: 0.86--1.63), and the value of this ratio still needs to be determined in dogs. Pulmonary artery diameters (average of the left and right pulmonary arteries) have also found to be predictive of death in patients with PH and bronchiectasis.[@b33-vmrr-7-019] CT reconstructions using multiplanar reformatting of the RV and left ventricular volumes can be calculated and compared. The RV to left ventricular volume ratios have been shown to correlate well with pulmonary artery pressures measured by cardiac catheterization (*R*=0.82, *P*\<0.001).[@b34-vmrr-7-019] In our study, multiplanar reformatting was not possible, but in three dogs, the average ratio of RV to left ventricular internal diameter was 106%; considering the right ventricle should be \<50% of the left ventricular internal diameter, this value was considered significant. Thus, a number of noninvasive CT measurements can be used to predict PH in people. The application of thoracic CT for noninvasively assessing the pulmonary arteries in dogs has already standardized the pulmonary artery size, using the bronchial lumen (internal diameter) at the same CT section as a reference, measured at the level of the fourth and eleventh ribs for the cranial and caudal lobar arteries, respectively, with BA ratios in normal dogs having a mean of 1.45±0.21 (99% confidence interval \[CI\] 1.34--1.56).[@b12-vmrr-7-019] The mean BA in our study, using the identical measurements (n=6), was 0.72 (range: 0.5--0.93), indicative of significant larger pulmonary arteries in our group of dogs as compared to the study by Cannon et al and should be considered as a potential CT index in predicting PH (2009).

In the five dogs that had bronchoscopy and BAL performed, there was no endoscopic evidence of traction bronchiectasis, and the cytology was consistent with a neutrophilic inflammation in only two dogs (50%--80% neutrophils). Bronchoscopy changes in IPF have been described as irregular mucosa, bronchial mucous, mild bronchiectasis, bronchomalacia; bacteria are not demonstrated on bronchoalveolar cytology or cultured, and in the four of the five dogs that had cellular BAL samples, neutrophils (50%--80%) predominated with macrophages (84%) in the other; although this is considered a normal cell type, the remainder (15/20) did not have any significant inflammation.[@b13-vmrr-7-019] In contrast, BAL cytology in EBP is consistent with an abnormal eosinophilia.[@b14-vmrr-7-019]

Limitations
===========

The main limitation of this study is the lack of lung histopathology and is due to the cultural opposition to necropsy in the region. Lung biopsy is associated with a high complication rate and mortality; two of eleven dogs and one of three dogs with ILD in two case series died as a complication.[@b16-vmrr-7-019],[@b35-vmrr-7-019] Lung biopsy was not offered to any of the clients due to the severe respiratory compromise of the dogs at the time of diagnosis. Anecdotally, a number of etiologies and pathogenesis including pollution and chronic high-pressure dynamics induced from chronic brachycephalic obstructive airway syndrome are possibilities. It cannot be established what the true prevalence of PH and chronic idiopathic ILD is in Pekingese without syncope and dyspnea as these dogs are unlikely to present to a veterinarian as chronic exercise intolerance could be assumed to be due to old age or brachycephalic obstructive airway syndrome. Ideally, a prospective study recruiting middle-aged Pekingese and performing sequential thoracic radiographs and echocardiography should be implemented. Postmortem with histopathology of the lungs should be able to elucidate the etiology of this syndrome but may prove difficult in this region.
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![Thoracic radiographs of an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).\
**Notes:** (**A**) Right lateral recumbent and (**B**) dorsoventral views. There is a mild diffuse interstitial lung pattern, more so in the right caudal lung lobe. Right ventricular enlargement is present with elevation of the cardiac apex (\*) seen on the lateral view. The lung severity score was 6/21.](vmrr-7-019Fig1){#f1-vmrr-7-019}

![Thoracic radiographs of an obese 7-year-old female Pekingese (case number 11) with pulmonary hypertension and interstitial lung disease.\
**Notes:** (**A**) Right lateral recumbent and (**B**) dorsoventral views. Positioning is compromised due to severe respiratory effort limiting patient restraint. There is an advanced diffuse interstitial lung pattern, more so in the right lung lobes. Right ventricular enlargement is present with elevation of the cardiac apex (\*) seen on the lateral view. The main stem bronchi are compressed and dyspnea-induced marked gastrophagia is present. The lung severity score was 7/21.](vmrr-7-019Fig2){#f2-vmrr-7-019}

![CT images in a lung window (window width 1,108 and window level −402) of an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).\
**Notes:** (**A**) Cranial at the level of the heart and (**B**) caudal at the level of the cranial liver transverse images. The right side of the dog is on the right of the images. The right side of the dog is on the left of the images. In (**A**), note the parenchymal bands (arrow) and honeycombing ventral to this. In (**B**), there is a more focal right caudal lobe dorsal ground-glass appearance indicative of early alveolar involvement. Note the more marked involvement of the right lung lobes.\
**Abbreviation:** CT, computed tomography.](vmrr-7-019Fig3){#f3-vmrr-7-019}

![CT transverse image in a lung window (window width 1,607 and window level −499) made caudal the heart. This was an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).\
**Notes:** The right side of the dog is on the left of the image. Note the parenchymal bands (arrows) and diffuse interstitial reticular pattern.\
**Abbreviation:** CT, computed tomography.](vmrr-7-019Fig4){#f4-vmrr-7-019}

![CT transverse post contrast image in a soft tissue window (window width 300 and window level 30) made through the heart at the level of the aortic (short arrow) and pulmonary trunks (long arrow). This was an obese 16-year-old male Pekinese with pulmonary hypertension and interstitial lung disease (case number 6).\
**Notes:** The dMPA:dAa was 1.6. The right side of the dog is on the left of the image.\
**Abbreviations:** CT, computed tomography; dMPA, main pulmonary artery diameter; dAa, ascending aorta diameter.](vmrr-7-019Fig5){#f5-vmrr-7-019}

###### 

Signalment, historical, clinical findings and outcome in 35 Pekingese with chronic pulmonary disease

  Case number   Sex      Body mass (kg)   Age (years)   Historical and clinical findings                                                             Duration of clinical signs prior to presentation (days)   Radiological cumulative lung score[a](#tfn1-vmrr-7-019){ref-type="table-fn"}   Survival (days) from date of diagnosis
  ------------- -------- ---------------- ------------- -------------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------ ----------------------------------------
  1             Male     4.20             18            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles                        7                                                         1                                                                              25
  2             Male     4.10             9             Exercise intolerance, syncope, cyanosis, crackles, heart murmur                              365                                                       0                                                                              4
  3             Male     7.20             10            Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur   4                                                         10                                                                             60
  4             Male     5.40             13            Exercise intolerance, syncope, cyanosis, crackles, heart murmur                              2                                                         0                                                                              6
  5             Male     5.70             15            Exercise intolerance, tachypnea, syncope, cyanosis, crackles                                 14                                                        4                                                                              210
  6             Male     6.30             16            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          180                                                       6                                                                              60
  7             Male     5.00             15            Exercise intolerance, syncope, dyspnea, cyanosis, crackles, heart murmur                     330                                                       3                                                                              30
  8             Male     9.00             8             Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur   30                                                        3                                                                              30
  9             Female   3.80             9             Exercise intolerance, tachypnea, dyspnea, cyanosis, crackles, heart murmur                   5                                                         12                                                                             20
  10            Male     7.00             13            Exercise intolerance, cough, tachypnea, syncope, cyanosis, heart murmur                      60                                                        5                                                                              3
  11            Female   6.30             7             Exercise intolerance, tachypnea, dyspnea, cyanosis, crackles, heart murmur                   365                                                       7                                                                              180
  12            Male     4.90             9             Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          180                                                       2                                                                              210
  13            Female   6.20             13            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles                        2                                                         2                                                                              1
  14            Female   4.90             14            Exercise intolerance, tachypnea, dyspnea, heart murmur                                       120                                                       0                                                                              420
  15            Female   6.20             12            Exercise intolerance, cough, tachypnea, dyspnea, crackles, heart murmur                      3                                                         4                                                                              690
  16            Female   8.30             12            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          1                                                         10                                                                             4
  17            Male     6.20             12            Exercise intolerance, cough, dyspnea, syncope, crackles, heart murmur                        730                                                       0                                                                              270
  18            Male     6.20             16            Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur   1                                                         3                                                                              11
  19            Female   5.60             14            Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur   30                                                        3                                                                              60
  20            Female   5.70             19            Cough, tachypnea, dyspnea, syncope, crackles, heart murmur                                   1                                                         3                                                                              120
  21            Female   4.10             12            Cough, dyspnea, crackles, heart murmur                                                       1                                                         4                                                                              1
  22            Male     7.20             13            Exercise intolerance, cough, dyspnea, crackles, heart murmur                                 180                                                       1                                                                              2
  23            Female   3.10             12            Exercise intolerance, cough, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur   365                                                       2                                                                              270
  24            Female   4.20             8             Cough, tachypnea, dyspnea, crackles, heart murmur                                            730                                                       2                                                                              265
  25            Male     7.30             10            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          30                                                        0                                                                              7
  26            Male     5.80             9             Tachypnea, heart murmur                                                                      180                                                       3                                                                              365
  27            Female   4.40             11            Exercise intolerance, cough, dyspnea, heart murmur                                           365                                                       0                                                                              365
  28            Male     4.50             14            Exercise intolerance, cough, heart murmur                                                    365                                                       5                                                                              992
  29            Male     4.40             13            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          180                                                       3                                                                              14
  30            Male     8.10             11            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          14                                                        4                                                                              14
  31            Male     4.30             11            Exercise intolerance, tachypnea, dyspnea, syncope, cyanosis, crackles, heart murmur          2                                                         5                                                                              7
  32            Male     5.00             14            Exercise intolerance, tachypnea, syncope, cyanosis, crackles, heart murmur                   21                                                        0                                                                              210
  33            Female   6.18             12            Exercise intolerance, cough, tachypnea, syncope, cyanosis, crackles, heart murmur            150                                                       2                                                                              210
  34            Male     6.00             8             Exercise intolerance, syncope, cyanosis, crackles, heart murmur                              60                                                        3                                                                              150
  35            Female   5.00             11            Coughing, heart murmur                                                                       3                                                         3                                                                              150

**Note:**

A cumulative lung severity score (0--21) was the sum of the seven individual lung lobe scores.

###### 

The radiographic and CT features of the five Pekingese diagnosed with pulmonary hypertension and interstitial lung disease

  Case number                                                                                                 6      10                                                    11     15                                                  18
  ----------------------------------------------------------------------------------------------------------- ------ ----------------------------------------------------- ------ --------------------------------------------------- ------
  Radiographic lung severity score (1--3) components (lobes 1--7)[a](#tfn3-vmrr-7-019){ref-type="table-fn"}                                                                                                                           
   L1                                                                                                         1      1                                                     1      1                                                   1
   L2                                                                                                         0      0                                                     1      0                                                   0
   L3                                                                                                         1      1                                                     1      2                                                   1
   L4                                                                                                         1      1                                                     1      0                                                   0
   L5                                                                                                         1      0                                                     1      1                                                   1
   L6                                                                                                         2      1                                                     1      0                                                   0
   L7                                                                                                         0      1                                                     1      0                                                   0
  Total radiographic lung severity score[b](#tfn4-vmrr-7-019){ref-type="table-fn"}                            6      5                                                     7      4                                                   3
  Pulmonary artery-to-vein ratio as measured on radiographs[c](#tfn5-vmrr-7-019){ref-type="table-fn"}                                                                                                                                 
   CrPA/CrPV                                                                                                  2.43                                                         0.9                                                        
   CdPA/CdPV                                                                                                  1      1.07                                                  1.3                                                        1.1
  CT determined pulmonary artery measurements                                                                                                                                                                                         
   BA ratios[d](#tfn6-vmrr-7-019){ref-type="table-fn"}                                                        0.7                                                          0.93   0.79                                                0.73
   dMPA/dAa[e](#tfn6-vmrr-7-019){ref-type="table-fn"}                                                         0.86   1.35                                                  1.63   0.76                                                1.15
  CT lobe HU[f](#tfn7-vmrr-7-019){ref-type="table-fn"}                                                                                                                                                                                
   L1                                                                                                         −373   −474                                                  −629   −417                                                −589
   L2                                                                                                         −559   −539                                                  −703   −165                                                −565
   L3                                                                                                         −585   −255                                                  −641   −130                                                −488
   L4                                                                                                         −294   −314                                                  −596   −713                                                −695
   L5                                                                                                         −293   −262                                                  −630   −652                                                −601
   L6                                                                                                         −304   −158                                                  −626   −471                                                −375
   L7                                                                                                         −516   −161                                                  −528   −222                                                −720
  CT% affected[g](#tfn8-vmrr-7-019){ref-type="table-fn"}                                                                                                                                                                              
   L1                                                                                                         47.7   33.5                                                  11.8   41.5                                                17.4
   L2                                                                                                         21.6   24.4                                                  1.4    76.9                                                20.8
   L3                                                                                                         17.9   64.2                                                  10.1   81.8                                                31.6
   L4                                                                                                         58.8   56.0                                                  16.4   0.0                                                 2.5
   L5                                                                                                         58.9   63.3                                                  11.6   8.6                                                 15.7
   L6                                                                                                         57.4   77.8                                                  12.2   33.9                                                47.4
   L7                                                                                                         27.6   77.4                                                  25.9   68.8                                                −1.0
  CT total lung lobe involvement[h](#tfn9-vmrr-7-019){ref-type="table-fn"}                                                                                                                                                            
   L1                                                                                                         3.8    1.3                                                   0.9    3.3                                                 0.7
   L2                                                                                                         0.5    0.6                                                   0.1    5.3                                                 0.5
   L3                                                                                                         1.3    9.4                                                   1.5    18.0                                                4.7
   L4                                                                                                         7.4    7.1                                                   2.1    0.0                                                 0.2
   L5                                                                                                         4.3    2.3                                                   0.8    0.3                                                 1.2
   L6                                                                                                         8.0    16.3                                                  1.7    2.4                                                 6.6
   L7                                                                                                         0.7    6.2                                                   1.4    5.5                                                 −0.0
   CT total lung nonaeration index[i](#tfn10-vmrr-7-019){ref-type="table-fn"}                                 26.2   43.3                                                  8.5    34.9                                                13.7
  General CT findings                                                                                                                                                                                                                 
  Traction bronchiectasis                                                                                     Yes    Yes                                                   No     No                                                  Yes
  Peribronchovascular interstitial thickening                                                                 Yes    Yes                                                   Yes    No                                                  Yes
  Subpleural thickening                                                                                       Yes    No                                                    No     No                                                  No
  Nodules                                                                                                     Yes    No                                                    No     No                                                  No
  Consolidated lung obscuring pulmonary vessels                                                               Yes    Yes                                                   No     No                                                  No
  Honeycombing                                                                                                Yes    Yes                                                   No     No                                                  Yes
  Parenchymal bands                                                                                           Yes    No                                                    Yes    No                                                  Yes
  Cavitatory lesions                                                                                          No     No                                                    No     No                                                  No
  Incidental findings on imaging                                                                                     Tracheal, main stem and accessory bronchus collapse          Pectus excavatum displacing the heart to the left   

**Notes:** Specifically the components of the lung pathological involvement severity scoring system and the total lung nonaeration index as calculated using radiographic and CT images respectively.

L1 pars cranialis left cranial lung lobe; L2 pars caudalis left cranial lung lobe; L3 left caudal lung lobe; L4 right cranial lung lobe; L5 right middle lung lobe; L6 right caudal lung lobe; L7 accessory lung lobe.

The sum of score (0--3, with 0 being no lung pattern and 3 being an alveolar pattern) assigned to each lung lobe (L1--L7) on radiographic interpretation. Maximum score =21.

The ratio of the left cranial lobar pulmonary artery to adjacent vein at the level of the fourth intercostal space on lateral thoracic radiograph (CrPA/CrPV) and the ratio of the left or right caudal lobar pulmonary artery at the level of the eleventh intercostal rib on dorsoventral thoracic radiograph (CdPA/CdPV).

Internal bronchial lumen-to-adjacent pulmonary arterial (BA) ratio. The main pulmonary artery diameter (dMPA), measured on transverse view at just distal to the bifurcation, and ascending aorta diameter (dAa) were measured using electronic calipers on the same transverse slice, and a ratio was determined.

CT HU, the Hounsfield unit value of the lung lobe.

CT% affected is the inverse% of aeration.

Refers to the amount of lung affected by pathology, depending on the contribution the lobe makes to overall lung volume.

Total lung nonaeration index is the sum of the lung involvement of lung lobes L1--L7.

**Abbreviations:** CT, computed tomography; CrPA/CrPV, cranial lobar pulmonary artery and vein; CdPA/CdPV, caudal lobar pulmonary artery and vein.
